SCHEMBL8259478

SCHEMBL8259478

Nc1cc(C(=O)N2CCC[C@H](c3nc(-c4ccc(F)cc4)no3)C2)ccc1F

nearest known ligand 0.80

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
GRM5 P41594 1/20 0.80
CLPP Q16740 1/20 0.80
MEN1 O00255 2/20 0.72
KMT2A Q03164 2/20 0.72
POLB P06746 1/20 0.70
RAB9A P51151 1/20 0.66
TSHR P16473 3/20 0.65
ALDH1A1 P00352 3/20 0.65
LMNA P02545 2/20 0.65
HTT P42858 2/20 0.65
SMN1; SMN2 Q16637 2/20 0.65
PKM P14618 1/20 0.64
NPSR1 Q6W5P4 2/20 0.62
HSD11B1 P28845 4/20 0.61
TP53 P04637 1/20 0.60
ALOX15 P16050 1/20 0.60
MAPK1 P28482 1/20 0.60
ATM Q13315 1/20 0.60
L3MBTL1 Q9Y468 1/20 0.60

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL192774 0.91 GRM5 (0.84) GRM5CLPPMEN1KMT2APOLB
SCHEMBL192775 0.91 GRM5 (0.84) GRM5CLPPMEN1KMT2APOLB
SCHEMBL192098 0.89 GRM5 (1.00) GRM5CLPPMEN1KMT2APOLB
SCHEMBL192099 0.89 GRM5 (1.00) GRM5CLPPMEN1KMT2APOLB
SCHEMBL193680 0.89 GRM5 (1.00) GRM5CLPPMEN1KMT2APOLB
SCHEMBL192654 0.89 GRM5 (0.80) GRM5CLPPMEN1KMT2APOLB
SCHEMBL192653 0.89 GRM5 (0.80) GRM5CLPPMEN1KMT2APOLB
SCHEMBL193390 0.89 GRM5 (0.80) GRM5CLPPMEN1KMT2APOLB
SCHEMBL193389 0.89 GRM5 (0.80) GRM5CLPPMEN1KMT2APOLB
SCHEMBL192923 0.86 GRM5 (0.82) GRM5CLPPMEN1KMT2APOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2006123249-A2 NOVEL OXADIAZOLE DERIVATIVES AND THEIR USE AS POSITIVE ALLOSTERIC MODULATORS OF METABOTROPIC GLUTAMATE RECEPTORS ADDEX PHARMA SA (CH) 2006-11-23 WO disclosed